Novaptech is a biotech company focused on aptamers, also known as synthetic antibodies. Taking advantage of its highly innovative technologies, Novaptech offers R&D services for the identification of custom aptamers and runs its own R&D programs for the development of biosensor devices for rapid tests / point-of-care analysis for pharma, animal health, environment and food safety. Biosensors are real time, quantitative, simple, portative and multiplex devices to skip lengthy lab analysis.
With more than 25 years expertise in oligonucleotide aptamers, Novaptech is a key player in the domain. Jean-Jacques Toulmé, worldwide KOL, is his Chief Scientific Officer. Novaptech developed active partnership with R&D departments of pharma, agro-food and water companies.
Novaptech has state of the art laboratory space for molecular biology. Selection is carried out on in house built automated platforms. Characterization of aptamers is performed by spectrometry. Aptamers are sorted from proprietary libraries of oligonucleotides.